A Phase 3, Multicentre, Randomized, Double-blind Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Subjects With Red Blood Cell Transfusion-dependent Anemia and Thrombocytopenia Due to IPSS Lower-risk Myelodysplastic Syndromes.
Evaluation of the Efficacy and Safety of Oral Azacitidine plus Best Supportive care versus
Placebo and Best Supportive care in subjects with red blood cell (RBC) transfusion-dependent
anemia and thrombocytopenia due to International Prognostic Scoring System (IPSS) lower risk
myelodysplastic syndromes (MDS).
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society